Lanean...

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes

Mantle cell lymphoma (MCL) is an incurable, typically aggressive subtype of non-Hodgkin lymphoma, accounting for 4%–7% of newly diagnosed non-Hodgkin lymphoma cases. Chemoresistance commonly ensues in MCL, and patients with this heterogeneous disease invariably relapse, underscoring the unmet need f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Clin Risk Manag
Egile Nagusiak: Vallumsetla, Nishanth, Paludo, Jonas, Kapoor, Prashant
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4644179/
https://ncbi.nlm.nih.gov/pubmed/26609233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S72943
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!